This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

RADIANCE trial

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The RADIANCE trial was a prospective, randomised, double-blind and placebo-controlled study which investigated the effect of withdrawing digoxin from patients with heart failure.

All patients were in sinus rhythm and had stable class II/III NYHA heart failure treated with diuretics, ACE inhibitors and digoxin.

93 patients were randomised to withdrawal of digoxin and 85 continued with digoxin.

Reference:

  • 1) Milton Packer, Mihai Gheorghiade, James B. Young, Peter J. Costantini, Kirkwood F. Adams, Robert J. Cody, L. Kent Smith, Lucy Van Voorhees, Lynn A. Gourley, M. King Jolly, for the RADIANCE Study. (1993) Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors. N Engl J Med, 329, 1-7.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.